This file is part of IDEAS , which uses RePEc data
[ Papers |
Articles |
Software |
Books |
Chapters |
Authors |
Institutions |
JEL Classification |
NEP reports |
Search |
New papers by email |
Author registration |
Rankings |
Volunteers |
FAQ |
Blog |
Help! ]
Pharmaceuticals and the Developing World Author info | Abstract | Publisher info | Download info | Related research | Statistics Michael Kremer
Pharmaceuticals have greatly improved health in developing countries, but many people in developing countries do not obtain even inexpensive pharmaceuticals and little pharmaceutical R&D is oriented toward products needed by developing countries, such as a malaria vaccine. Access to existing products could be improved by facilitating differential pricing, for example by subsidizing donation programs, and reforming health care delivery. R&D incentives could be improved if rich countries or international organization committed to purchase needed products when they are developed and make them available to the poor.
To download:
If you experience problems downloading a file, check if you have the
proper application to
view it first. Information about this may be contained
in the File-Format links below. In case of further problems read
the IDEAS help
file . Note that these files are not on the IDEAS
site. Please be patient as the files may be large.
As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.
Article provided by American Economic Association in its journal Journal of Economic Perspectives .
Volume (Year): 16 (2002)
Issue (Month): 4 (Fall)
Pages: 67-90
Download reference. The following formats are available: HTML ,
plain text ,
BibTeX ,
RIS (EndNote),
ReDIF
Handle: RePEc:aea:jecper:v:16:y:2002:i:4:p:67-90Contact details of provider: Email: Web page: http://www.aeaweb.org/jep/ More information through EDIRC
Order Information: Web: http://www.aeaweb.org/subscribe.html
For technical questions regarding this item, or to correct its listing, contact: (Christopher F. Baum).
Keywords: References listed on IDEAS Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile , click on "citations" and make appropriate adjustments.:
Leonard, Kenneth L., 2002.
"When both states and markets fail: asymmetric information and the role of NGOs in African health care ,"
International Review of Law and Economics ,
Elsevier, vol. 22(1), pages 61-80, July.
[Downloadable!] (restricted)
Robert W. Fogel, 1984.
"Nutrition and the Decline in Mortality Since 1700: Some Preliminary Findings ,"
NBER Working Papers
1402, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted)
Michael Kremer, 2000.
"Creating Markets for New Vaccines Part II: Design Issues ,"
NBER Working Papers
7717, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted)
Michael Kremer, 2000.
"Creating Markets for New Vaccines Part I: Rationale ,"
NBER Working Papers
7716, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted)
Full
references Cited by : (explanations , Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile , click on "citations" and make appropriate adjustments.)
Reto Foellmi und Josef Zweimüller, .
"Inequality and Economic Growth - European Versus U.S. Experiences ,"
IEW - Working Papers
iewwp158, Institute for Empirical Research in Economics - IEW.
[Downloadable!]
Other versions: Ken Tabata & Testuya Shinkai & Satoru Tanaka & Makoto Okamura, 2005.
"Parallel Imports, Drag Price Control and Pharmaceutical Innovation ,"
Discussion Paper Series
26, School of Economics, Kwansei Gakuin University, revised Aug 2005.
[Downloadable!]
Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry ,"
Levine's Working Paper Archive
228400000000000002, UCLA Department of Economics.
[Downloadable!]
Other versions:
Daron Acemoglu & Joshua Linn, 2003.
"Market Size in Innovation: Theory and Evidence From the Pharmaceutical Industry ,"
NBER Working Papers
10038, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted) Daron Acemoglu & Joshua Linn, 2004.
"Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry ,"
The Quarterly Journal of Economics ,
MIT Press, vol. 119(3), pages 1049-1090, August.
[Downloadable!] (restricted) Harsha Thirumurthy & Joshua Graff-Zivin & Markus Goldstein, 2005.
"The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya ,"
NBER Working Papers
11871, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted)
Other versions: Gancia, Gino, 2003.
"Globalization, Divergence and Stagnation ,"
Seminar Papers
720, Stockholm University, Institute for International Economic Studies.
[Downloadable!]
Other versions: Chris Papageorgiou & Andreas Savvides & Marios Zachariadis, .
"International Medical Technology Diffusion ,"
University of Cyprus Working Papers in Economics
2-2005, University of Cyprus Department of Economics.
[Downloadable!]
Other versions:
Chris Papageorgiou & Andreas Savvides & Marios Zachariadis, 2006.
"International Medical Technology Diffsion ,"
2006 Meeting Papers
23, Society for Economic Dynamics.
[Downloadable!] Papageorgiou, Chris & Savvides, Andreas & Zachariadis, Marios, 2007.
"International medical technology diffusion ,"
Journal of International Economics ,
Elsevier, vol. 72(2), pages 409-427, July.
[Downloadable!] (restricted) Chris Papageorgiou & Andreas Savvides & Marios Zachariadis, .
"International Medical R&D Spillovers ,"
Departmental Working Papers
2004-03, Department of Economics, Louisiana State University.
[Downloadable!]
Tomas Philipson & Stephane Mechoulan, 2003.
"Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets ,"
NBER Working Papers
9598, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted)
Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2007.
"Who's Doing What in Pharmaceutical R&D? Model ,"
Working Papers
2, Economics, Markets, Institutions - IMT Institutions, Markets, Technologies - Institute for Advanced Studies Lucca.
[Downloadable!]
Tomas Philipson & Stephane Mechoulan & Anupam Jena, 2006.
"IP & External Consumption Effects: Generalizations from Health Care Markets ,"
NBER Working Papers
11930, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted)
Hendrik P. van Dalen & Mieke Reuser, 2005.
"What Drives Donor Funding in Population Assistance Programs? ,"
Tinbergen Institute Discussion Papers
05-062/1, Tinbergen Institute.
[Downloadable!]
Shandre M. Thangavelu & Sanja Samirana Pattnayak, 2006.
"Linkages and Spillovers from Foreign Ownership in the Indian Pharmaceutical Firms ,"
SCAPE Policy Research Working Paper Series
0605, National University of Singapore, Department of Economics, SCAPE.
[Downloadable!]
Margaret E. Blume-Kohout & Neeraj Sood, 2008.
"The Impact of Medicare Part D on Pharmaceutical R&D ,"
NBER Working Papers
13857, National Bureau of Economic Research, Inc.
[Downloadable!] (restricted)
Chris Papageorgiou & Petia Stoytcheva, .
"What Do We Know About the Impact of AIDS on Cross-Country Income So Far? ,"
Departmental Working Papers
2005-01, Department of Economics, Louisiana State University.
[Downloadable!]
Access and
download statistics Did you know? IDEAS also covers the most complete directory of Economics departments and institutes, EDIRC .
This page was last updated on 2008-7-20.
This information is provided to you by IDEAS at the Department of Economics , College of Liberal Arts and Sciences , University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics .